12K views · 164 reactions | CFTR modulators like Trikafta represent great progress in addressing the underlying cause of cystic fibrosis — but they do not cure the disease, and not everyone can benefit. Like Gina Ruiz, a 29-year-old living with CF who has two nonsense mutations. She shares her experience and some misconceptions about the disease. Learn more facts about CF: https://www.cff.org/intro-cf/dispelling-misconceptions-about-cystic-fibrosis | Cystic Fibrosis Foundation | Facebook